Bioprinting is an emerging technique for the fabrication of three-dimensional (3D) cell-laden constructs. However, the progress for generating a 3D complex physiological microenvironment has been hampered by a lack of advanced cell-responsive bioinks that enable bioprinting with high structural fidelity, particularly in the case of extrusion-based bioprinting. Herein, we report a novel strategy to directly bioprint cell-laden constructs using bioinks made of gelatin methacryloyl (GelMA) physical gels (GPGs). Attributed to their shear-thinning and self-healing properties, the GPG bioinks could retain the shape and form integral structures after deposition, allowing for subsequent UV crosslinking for permanent stabilization. We showed the structural fidelity by bioprinting various 3D structures that are typically challenging to fabricate using conventional bioinks under extrusion modes. Moreover, the use of the GPG bioinks enabled direct bioprinting of highly porous and soft constructs at relatively low concentrations (down to 3%) of GelMA. We also demonstrated that the bioprinted constructs not only permitted cell survival but also enhanced cell proliferation as well as spreading at lower concentrations of the GPG bioinks. We believe our strategy of bioprinting will provide many opportunities in convenient fabrication of 3D cell-laden constructs for applications in tissue engineering, regenerative medicine, and pharmaceutical screening.